SCHEMBL18844516

SCHEMBL18844516

NC1COC(CO[PH](=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18866637 0.79
SCHEMBL19174674 0.79
SCHEMBL8677271 0.78
Butane SCHEMBL10485249 0.72 SMN1; SMN2 (0.42)
SCHEMBL18844529 0.69
SCHEMBL1275854 0.68
SCHEMBL20124852 0.68
SCHEMBL9680409 0.68
SCHEMBL20124842 0.68
SCHEMBL23734197 0.67 LMNA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336785-B2 Methods for synthesizing nucleotide analogues with disulfide linkers QIAGEN SCIENCES, LLC (US) 2019-07-02 US disclosed
US-10301346-B2 Nucleotide analogues QIAGEN SCIENCES, LLC (US) 2019-05-28 US disclosed
US-20170137869-A1 METHODS FOR SYNTHESIZING NUCLEOTIDE ANALOGUES WITH DISULFIDE LINKERS IsoPlexis Corporation 2017-05-18 US disclosed
US-20170130051-A1 NUCLEOTIDE ANALOGUES IsoPlexis Corporation 2017-05-11 US disclosed